SIREN : 388461154
CNRS INNOVATION is a French company founded 33 years ago, specialized in the sector Gestion de fonds. Based in BOULOGNE-BILLANCOURT (92100), this company of category ETI shows in 2024 a revenue of 14.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 614 321 € | 14 325 865 € | 14 251 159 € | 14 878 086 € | 9 073 989 € | 4 463 919 € | 4 180 982 € | 4 159 055 € | 4 350 081 € |
| Net income | 972 596 € | -952 819 € | 1 360 824 € | 1 456 493 € | 236 634 € | 5 768 € | 83 509 € | -119 768 € | -113 961 € |
| EBITDA | 498 973 € | 801 403 € | 1 676 389 € | 2 054 092 € | 532 752 € | 144 563 € | 125 266 € | -32 152 € | -216 367 € |
| Net margin | 6.7% | -6.7% | 9.5% | 9.8% | 2.6% | 0.1% | 2.0% | -2.9% | -2.6% |
In 2024, CNRS INNOVATION achieves revenue of 14.6 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +16.4%. Vs 2023: +2%. After deducting consumption (0 €), gross margin stands at 14.6 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 499 k€, representing 3.4% of revenue. Warning negative scissor effect: despite revenue change (+2%), EBITDA varies by -38%, reducing margin by 2.2 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 973 k€, i.e. 6.7% of revenue. This profit can be retained or distributed to shareholders.
14 614 321 €
14 614 321 €
498 973 €
469 256 €
972 596 €
3.2%
The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 21%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 7.9% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
3.587%
21.474%
7.865%
0.124
34.2%
In 2024, the debt ratio of CNRS INNOVATION (3.59) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of CNRS INNOVATION (21.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of CNRS INNOVATION (0.12) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 100.25. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 34.3x. Operating income very largely covers interest expenses: high safety margin.
100.246
34.342
In 2024, the liquidity ratio of CNRS INNOVATION (100.25) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of CNRS INNOVATION (34.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 14 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 63 days. Excellent situation: suppliers finance 49 days of the operating cycle (retail model). WCR is negative (-299 days): operations structurally generate cash. Notable WCR improvement over the period (-167%), freeing up cash.
-12 135 878 €
14 j
63 j
0 j
-299 j
Based on 62 transactions of similar company sales
in 2024,
the value of CNRS INNOVATION is estimated at
3 969 353 €
(range 1 471 065€ - 9 259 064€).
With an EBITDA of 498 973€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.30x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare CNRS INNOVATION with other companies in the same sector:
The revenue of CNRS INNOVATION in 2024 is 14.6 M€.
Yes, CNRS INNOVATION generated a net profit of 973 k€ in 2024.
The headquarters of CNRS INNOVATION is located in BOULOGNE-BILLANCOURT (92100), in the department Hauts-de-Seine.
The tax return of CNRS INNOVATION is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
CNRS INNOVATION operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.